Compounds > rolipram
Page last updated: 2024-08-16

rolipram and atl 146e

rolipram has been researched along with atl 146e in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, L; Linden, J; Okusa, MD; Rosin, DL; Smith, DF; Sullivan, G1
Beller, GA; Glover, DK; Linden, J; Macdonald, TL; Rieger, JM; Riou, LM; Ruiz, M; Sullivan, GW; Watson, DD1
Lappas, CM; Linden, J; Rieger, JM1
Chevalier, RL; Forbes, MS; Lange-Sperandio, B; Linden, J; Okusa, MD; Thornhill, B1

Other Studies

4 other study(ies) available for rolipram and atl 146e

ArticleYear
Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Kidney international, 2001, Volume: 59, Issue:6

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Kidney Injury; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purines; Reactive Oxygen Species; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reperfusion Injury; Respiratory Burst; Rolipram

2001
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine A2 Receptor Agonists; Animals; Cardiotonic Agents; Coronary Circulation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dogs; Drug Therapy, Combination; Myocardial Infarction; Myocardial Reperfusion Injury; Myocarditis; Phosphodiesterase Inhibitors; Purines; Respiratory Burst; Rolipram

2005
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
    Journal of immunology (Baltimore, Md. : 1950), 2005, Jan-15, Volume: 174, Issue:2

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Cell Line; Cyclic AMP; Cyclohexanecarboxylic Acids; Gene Dosage; Humans; Interferon-gamma; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Receptor, Adenosine A2A; Receptors, Antigen, T-Cell; RNA, Messenger; Rolipram; Triazines; Triazoles

2005
A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
    Nephron. Experimental nephrology, 2005, Volume: 100, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Apoptosis; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Fibrosis; Inflammation; Kidney Diseases; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Purines; Receptors, Adenosine A2; Rolipram; Ureteral Obstruction

2005